These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1471200)

  • 1. Expression of pulmonary cytochrome P4501A1 and carcinogen DNA adduct formation in high risk subjects for tobacco-related lung cancer.
    Bartsch H; Castegnaro M; Rojas M; Camus AM; Alexandrov K; Lang M
    Toxicol Lett; 1992 Dec; 64-65 Spec No():477-83. PubMed ID: 1471200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
    Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
    IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinogen metabolism and DNA adducts in human lung tissues as affected by tobacco smoking or metabolic phenotype: a case-control study on lung cancer patients.
    Bartsch H; Petruzzelli S; De Flora S; Hietanen E; Camus AM; Castegnaro M; Geneste O; Camoirano A; Saracci R; Giuntini C
    Mutat Res; 1991; 250(1-2):103-14. PubMed ID: 1944327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: results from a case--control multicenter study on lung cancer patients.
    Bartsch H; Petruzzelli S; De Flora S; Hietanen E; Camus AM; Castegnaro M; Alexandrov K; Rojas M; Saracci R; Giuntini C
    Environ Health Perspect; 1992 Nov; 98():119-24. PubMed ID: 1336722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic polymorphism affecting DNA binding and excretion of carcinogens in humans.
    Bartsch H; Rojas M; Alexandrov K; Camus AM; Castegnaro M; Malaveille C; Anttila S; Hirvonen K; Husgafvel-Pursiainen K; Hietanen E
    Pharmacogenetics; 1995; 5 Spec No():S84-90. PubMed ID: 7581496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-lasting effects of tobacco smoking on pulmonary drug-metabolizing enzymes: a case-control study on lung cancer patients.
    Petruzzelli S; Camus AM; Carrozzi L; Ghelarducci L; Rindi M; Menconi G; Angeletti CA; Ahotupa M; Hietanen E; Aitio A
    Cancer Res; 1988 Aug; 48(16):4695-700. PubMed ID: 3135117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pulmonary DNA adduct levels, measured by 32P-postlabelling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers.
    Geneste O; Camus AM; Castegnaro M; Petruzzelli S; Macchiarini P; Angeletti CA; Giuntini C; Bartsch H
    Carcinogenesis; 1991 Jul; 12(7):1301-5. PubMed ID: 2070496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective metabolism of (-)-benzo[a]pyrene-7,8-diol by human lung microsomes and peripheral blood lymphocytes: effect of smoking.
    Rojas M; Camus AM; Alexandrov K; Husgafvel-Pursiainen K; Anttila S; Vainio H; Bartsch H
    Carcinogenesis; 1992 Jun; 13(6):929-33. PubMed ID: 1600613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental factors and aryl hydrocarbon hydroxylase activity (CYP1A1 phenotype) in human lymphocytes.
    Kiyohara C; Hirohata T
    J Epidemiol; 1997 Dec; 7(4):244-50. PubMed ID: 9465551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tobacco smoke on the gene expression of the Cyp1a, Cyp2b, Cyp2e, and Cyp3a subfamilies in mouse liver and lung: relation to single strand breaks of DNA.
    Villard PH; Seree EM; Re JL; De Meo M; Barra Y; Attolini L; Dumenil G; Catalin J; Durand A; Lacarelle B
    Toxicol Appl Pharmacol; 1998 Feb; 148(2):195-204. PubMed ID: 9473526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo.
    Kato S; Bowman ED; Harrington AM; Blomeke B; Shields PG
    J Natl Cancer Inst; 1995 Jun; 87(12):902-7. PubMed ID: 7666479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of pulmonary cytochrome P450IA and metabolic activities associated with P450IA1 and P450IA2 isozymes in lung cancer patients.
    Anttila S; Vainio H; Hietanen E; Camus AM; Malaveille C; Brun G; Husgafvel-Pursiainen K; Heikkilä L; Karjalainen A; Bartsch H
    Environ Health Perspect; 1992 Nov; 98():179-82. PubMed ID: 1336724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
    Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
    Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical and molecular biological studies on human placental cigarette smoke-inducible cytochrome P-450-dependent monooxygenase activities.
    Pasanen M; Haaparanta T; Sundin M; Sivonen P; Vakakangas K; Raunio H; Hines R; Gustafsson JA; Pelkonen O
    Toxicology; 1990 May; 62(2):175-87. PubMed ID: 1693794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer.
    Nakajima T; Elovaara E; Anttila S; Hirvonen A; Camus AM; Hayes JD; Ketterer B; Vainio H
    Carcinogenesis; 1995 Apr; 16(4):707-11. PubMed ID: 7728947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of cigarette smoke on aryl hydrocarbon hydroxylase activity and cytochrome P450 content in rat liver and lung microsomes.
    Kushinsky R; Louis CJ
    Oncology; 1976; 33(5-6):197-200. PubMed ID: 1026852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of cytochrome P4501A1 promoter in the lung is associated with tobacco smoking.
    Anttila S; Hakkola J; Tuominen P; Elovaara E; Husgafvel-Pursiainen K; Karjalainen A; Hirvonen A; Nurminen T
    Cancer Res; 2003 Dec; 63(24):8623-8. PubMed ID: 14695173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.
    Culp SJ; Roberts DW; Talaska G; Lang NP; Fu PP; Lay JO; Teitel CH; Snawder JE; Von Tungeln LS; Kadlubar FF
    Mutat Res; 1997 Aug; 378(1-2):97-112. PubMed ID: 9288889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers.
    Bartsch H; Nair U; Risch A; Rojas M; Wikman H; Alexandrov K
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):3-28. PubMed ID: 10667460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in risk of lung cancer: Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts.
    Mollerup S; Berge G; Baera R; Skaug V; Hewer A; Phillips DH; Stangeland L; Haugen A
    Int J Cancer; 2006 Aug; 119(4):741-4. PubMed ID: 16557573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.